Skip to content

Clinical trials

Phase 1/2 Carcinoma, Hepatocellular trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Country / region: Taiwan Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20052
20061
20092
20111
20121
20144
20151
20161
20171
20194
20201
20224
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11
Completed10
Recruiting7
Unknown status3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
National Health Research Institutes, Taiwan2
National Taiwan University Hospital2
Taiwan Liposome Company2
Adherex Technologies, Inc.1
Arbutus Biopharma Corporation1
AstraZeneca1
Daiichi Sankyo1
DualityBio Inc.1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular33
Liver Neoplasms8
Neoplasms4
Colorectal Neoplasms3
Melanoma3
Squamous Cell Carcinoma of Head and Neck3
Uterine Cervical Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Stomach Neoplasms2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.